Junction Bioscience
AI Hypothesis Engine for Molecular Discovery
Junction Bioscience operates in healthcare based in New York City, NY, USA.
Profile
Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control over the molecular basis of disease. We focus on the intersection of neuroinflammation and immunology where uncommon molecular insights position us to develop best-in-class therapies for millions of patients in need.
Its activity falls under healthcare; the profile below is assembled from public directory data.
Its base of operations is New York City, NY, USA.
Its current recorded stage is Winter 2024.
Recorded headcount: 1 employees.
Directory analysis
Junction Bioscience is developing an autonomous AI scientist that drives the discovery of transformative medicines, with a focus on neuroinflammation and immunology. Its AI hypothesis engine iterates on breakthrough chemistry from the laboratory to gain clarity and control over the molecular basis of disease, aiming to produce best‑in‑class therapies for millions of patients.
Positioning: The company targets a niche intersection of AI‑driven drug discovery and neuroimmunology, positioning itself to address high‑impact therapeutic areas. As an early‑stage, single‑employee venture, it is still establishing its commercial path and market footprint.
Note: Junction Bioscience is a single‑employee AI‑focused drug discovery startup headquartered in New York City.
Auto-generated directory analysis from public data · updated 10 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | New York City, NY, USA |
| Country | USA |
| Employees | 1 |
| Stage | Winter 2024 |
Website: www.junction.bio
Browse related
Create a free account